Thrombospondin-4 A387P polymorphism is not associated with coronary artery disease and myocardial infarction in the Chinese Han population

Xiaoyang Zhou, Jianfeng Huang, Jianhong Chen, Jiangong Zhao, Wenjie Yang, Xiaoling Wang, Dongfeng Gu

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Recently, conflicting data have been reported regarding the possible contribution of the TSP-4 (thrombospondin-4) A387P polymorphism to CAD (coronary artery disease) or MI (myocardial infarction). To investigate a possible association between the A387P polymorphism and CAD or MI in the Chinese Man population, we conducted a case-controlled study including 817 patients with angiographicalty verified CAD or those who survived an acute MI and 847 control subjects. The TSP-4 A387P polymorphism was determined by PCR and PCR-RFLP (restriction-fragment-length polymorphism) analysis. The prevalence of the 387P allele was 3.8% in the healthy controls, which was less frequent than those in Western populations (19.6-23.2%). No association of the A387P polymorphism with an altered risk of CAD, MI or premature MI was found in our present study (CG + CC compared with GG, PCAD = 0.51, PMI = 0.13, P PrematureMI = 0.17 respectively). We concluded that a relationship between the TSP-4 A387P polymorphism and CAD or MI was unlikely in our population. Additional investigations should be performed in populations at different risk of coronary events in order to elucidate further the possible contribution of this polymorphism to cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)495-500
Number of pages6
JournalClinical Science
Volume106
Issue number5
DOIs
StatePublished - May 1 2004

Fingerprint

Myocardial Infarction
Coronary Artery Disease
Population
Restriction Fragment Length Polymorphisms
Polymerase Chain Reaction
thrombospondin 4
Coronary Artery Disease, Autosomal Dominant, 1
Cardiovascular Diseases
Alleles

Keywords

  • Association study
  • Coronary artery disease
  • Myocardial infarction
  • Polymorphism
  • Thrombospondin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Thrombospondin-4 A387P polymorphism is not associated with coronary artery disease and myocardial infarction in the Chinese Han population. / Zhou, Xiaoyang; Huang, Jianfeng; Chen, Jianhong; Zhao, Jiangong; Yang, Wenjie; Wang, Xiaoling; Gu, Dongfeng.

In: Clinical Science, Vol. 106, No. 5, 01.05.2004, p. 495-500.

Research output: Contribution to journalArticle

Zhou, Xiaoyang ; Huang, Jianfeng ; Chen, Jianhong ; Zhao, Jiangong ; Yang, Wenjie ; Wang, Xiaoling ; Gu, Dongfeng. / Thrombospondin-4 A387P polymorphism is not associated with coronary artery disease and myocardial infarction in the Chinese Han population. In: Clinical Science. 2004 ; Vol. 106, No. 5. pp. 495-500.
@article{01f06c86246b422182bbc1045b7fbc90,
title = "Thrombospondin-4 A387P polymorphism is not associated with coronary artery disease and myocardial infarction in the Chinese Han population",
abstract = "Recently, conflicting data have been reported regarding the possible contribution of the TSP-4 (thrombospondin-4) A387P polymorphism to CAD (coronary artery disease) or MI (myocardial infarction). To investigate a possible association between the A387P polymorphism and CAD or MI in the Chinese Man population, we conducted a case-controlled study including 817 patients with angiographicalty verified CAD or those who survived an acute MI and 847 control subjects. The TSP-4 A387P polymorphism was determined by PCR and PCR-RFLP (restriction-fragment-length polymorphism) analysis. The prevalence of the 387P allele was 3.8{\%} in the healthy controls, which was less frequent than those in Western populations (19.6-23.2{\%}). No association of the A387P polymorphism with an altered risk of CAD, MI or premature MI was found in our present study (CG + CC compared with GG, PCAD = 0.51, PMI = 0.13, P PrematureMI = 0.17 respectively). We concluded that a relationship between the TSP-4 A387P polymorphism and CAD or MI was unlikely in our population. Additional investigations should be performed in populations at different risk of coronary events in order to elucidate further the possible contribution of this polymorphism to cardiovascular disease.",
keywords = "Association study, Coronary artery disease, Myocardial infarction, Polymorphism, Thrombospondin",
author = "Xiaoyang Zhou and Jianfeng Huang and Jianhong Chen and Jiangong Zhao and Wenjie Yang and Xiaoling Wang and Dongfeng Gu",
year = "2004",
month = "5",
day = "1",
doi = "10.1042/CS20030322",
language = "English (US)",
volume = "106",
pages = "495--500",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "5",

}

TY - JOUR

T1 - Thrombospondin-4 A387P polymorphism is not associated with coronary artery disease and myocardial infarction in the Chinese Han population

AU - Zhou, Xiaoyang

AU - Huang, Jianfeng

AU - Chen, Jianhong

AU - Zhao, Jiangong

AU - Yang, Wenjie

AU - Wang, Xiaoling

AU - Gu, Dongfeng

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Recently, conflicting data have been reported regarding the possible contribution of the TSP-4 (thrombospondin-4) A387P polymorphism to CAD (coronary artery disease) or MI (myocardial infarction). To investigate a possible association between the A387P polymorphism and CAD or MI in the Chinese Man population, we conducted a case-controlled study including 817 patients with angiographicalty verified CAD or those who survived an acute MI and 847 control subjects. The TSP-4 A387P polymorphism was determined by PCR and PCR-RFLP (restriction-fragment-length polymorphism) analysis. The prevalence of the 387P allele was 3.8% in the healthy controls, which was less frequent than those in Western populations (19.6-23.2%). No association of the A387P polymorphism with an altered risk of CAD, MI or premature MI was found in our present study (CG + CC compared with GG, PCAD = 0.51, PMI = 0.13, P PrematureMI = 0.17 respectively). We concluded that a relationship between the TSP-4 A387P polymorphism and CAD or MI was unlikely in our population. Additional investigations should be performed in populations at different risk of coronary events in order to elucidate further the possible contribution of this polymorphism to cardiovascular disease.

AB - Recently, conflicting data have been reported regarding the possible contribution of the TSP-4 (thrombospondin-4) A387P polymorphism to CAD (coronary artery disease) or MI (myocardial infarction). To investigate a possible association between the A387P polymorphism and CAD or MI in the Chinese Man population, we conducted a case-controlled study including 817 patients with angiographicalty verified CAD or those who survived an acute MI and 847 control subjects. The TSP-4 A387P polymorphism was determined by PCR and PCR-RFLP (restriction-fragment-length polymorphism) analysis. The prevalence of the 387P allele was 3.8% in the healthy controls, which was less frequent than those in Western populations (19.6-23.2%). No association of the A387P polymorphism with an altered risk of CAD, MI or premature MI was found in our present study (CG + CC compared with GG, PCAD = 0.51, PMI = 0.13, P PrematureMI = 0.17 respectively). We concluded that a relationship between the TSP-4 A387P polymorphism and CAD or MI was unlikely in our population. Additional investigations should be performed in populations at different risk of coronary events in order to elucidate further the possible contribution of this polymorphism to cardiovascular disease.

KW - Association study

KW - Coronary artery disease

KW - Myocardial infarction

KW - Polymorphism

KW - Thrombospondin

UR - http://www.scopus.com/inward/record.url?scp=2442446367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442446367&partnerID=8YFLogxK

U2 - 10.1042/CS20030322

DO - 10.1042/CS20030322

M3 - Article

VL - 106

SP - 495

EP - 500

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 5

ER -